Scientists have utilised AI to predict T cell receptors, advancing personalised medicine, and boosting immunotherapy and vaccine development.
The field of RNA therapeutics has expanded incredibly in the past 30 years, and mRNA-based COVID-19 vaccines were just the start.
Clinical trials of an mRNA vaccine have begun, and researchers expect broadly positive outcomes in the fight against the widespread illness.
The drug donanemab is being hailed as a turning point in the fight against Alzheimer’s, following a global trial that confirms it can slow cognitive decline.
German doctors have reported success in treating patients with severe lupus, using cell treatments like those used for some forms of blood cancer.
Professor Jamie Rossjohn is internationally recognised for using structural biology to investigate how T cells can respond to viral infections or cause autoimmunity. Now, he's been named a fellow of the oldest science academy in the world.
The case is growing stronger for COVID-19 vaccine mixing-and-matching, with recent data showing high efficacy and protection against SARS-CoV-2 virus strains.
After a horrific 2017 flu season, there's more interest than ever in developing a better, more universal vaccine. T-cells might hold the answer.
Researchers focus on immune cells to save eyesight in adults and premature babies.
An immunology mystery surrounding the cellular basis for our biological uniqueness has been solved – with groundbreaking implications for treating autoimmune diseases.
Dummy text
